Prenatal screening for cystic fibrosis: 5 years' experience reviewed
References (17)
- et al.
Prenatal screening for cystic fibrosis
Lancet
(1992) Couple screening for cystic fibrosis
Lancet
(1991)- et al.
Couple screening for cystic fibrosis
Lancet
(1993) - et al.
Prenatal screening for cystic fibrosis
Lancet
(1994) Population screening for cystic fibrosis
Am J Hum Genet
(1990)Cystic fibrosis in the United Kingdom 1977-85: an improving picture
BMJ
(1988)- et al.
Tay-Sachs disease: heterozygote screening and prenatal diagnosis
- et al.
The clinical approach to thalassaemia
(1984)
Cited by (56)
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening
2014, Journal of Cystic FibrosisCitation Excerpt :Population-based carrier screening for CF has been discussed since 1991 when CFTR mutation detection became relatively easy to do. A successful program ran in Edinburgh for many years and small programs have been developed in other European centers [7–11]. Only the United States offers a population-based program (although fee-for-service) following the recommendation of the American College of Obstetricians and Medical Geneticists [12].
Cystic fibrosis carrier screening
2013, Paediatric Respiratory ReviewsCitation Excerpt :The French and UK statements acknowledge the right of the individual to make the choice to have screening, but are unable to support a recommendation that encompasses CF carrier screening for the population. The earliest CF carrier screening program began in Edinburgh in 1991.43 This used the model of couple screening and was associated with a high uptake and a 50% reduction in CF live births.44
Benchmarks for Cystic Fibrosis carrier screening: A European consensus document
2010, Journal of Cystic FibrosisCitation Excerpt :The former involves informing them jointly of their risk status: which is ‘high’ when both partners are carriers or ‘low’ where neither is a carrier or when only one tested positive. This has been advocated as an effective and cost-efficient method of screening [57–59]. However, one major shortcoming is that this type of couple screening violates confidentiality principles where individuals have a right to receive their results independently from their partner's.
Prenatal screening for cystic fibrosis
2003, Clinics in Laboratory MedicineVariables that underlie cost efficacy of prenatal screening
2002, Obstetrics and Gynecology Clinics of North America23. The Dor Yeshorim story: Community-based carrier screening for Tay-Sachs disease
2001, Advances in Genetics